Trial Information
Inclusion Criteria:
- 18 years of age or older
- Body weight >/= 99lbs
- ECOG 0-2
- Anemia results from cancer, chemotherapy, radiotherapy or an association with
hormonal therapy or immunotherapy
- Screening hemoglobin level of = 11.0 g/dL for men or = 10.0 for women
Exclusion Criteria:
- History of or concurrent second malignancy
- Evidence of primary or metastatic malignancy involving the Central Nervous System
Type of Study:
Interventional
Study Design:
Endpoint Classification: Efficacy Study, Primary Purpose: Treatment
Authority:
United States: Food and Drug Administration
Study ID:
CR010549
NCT ID:
NCT00083434
Start Date:
February 2004
Completion Date:
October 2004
Related Keywords:
- Anemia
- Cancer
- Anemia
- Cancer
- Anemia
Name | Location |
California Cancer Center |
Fresno, California 93720 |
Advanced Urology Medical Center |
Anaheim, California 92801 |
Shapiro, Stafford & Yee |
Arcadia, California 91007 |
Tukoi Research |
North Miami, Florida 33161 |
Hanover Medical Specialists, PA |
Wilmington, North Carolina 28401 |
Madigan Army Medical Center Urology Services |
Tacoma, Washington 98431-5000 |